{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:24:01Z","timestamp":1792513441812,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.tmaid.2022.102289","type":"journal-article","created":{"date-parts":[[2022,2,25]],"date-time":"2022-02-25T16:43:36Z","timestamp":1645807416000},"page":"102289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["National review of reported Yellow fever vaccine incidents in the UK"],"prefix":"10.1016","volume":"47","author":[{"given":"Roshina","family":"Gnanadurai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ines","family":"Campos-Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanch","family":"Kanagarajah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Geary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Simons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipti","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"40","key":"10.1016\/j.tmaid.2022.102289_bib1","first-page":"349","article-title":"Yellow fever vaccine. WHO position paper","volume":"78","author":"World Health Organization","year":"2003","journal-title":"Relev Epidemiol Hebd"},{"key":"10.1016\/j.tmaid.2022.102289_bib2","doi-asserted-by":"crossref","unstructured":"O. Tomori, \u201cYellow fever: the recurring plague,\u201d Crit Rev Clin Lab Sci, vol. 41, no. 4. Taylor & Francis, pp. 391\u2013427, 19-Jan-2004.","DOI":"10.1080\/10408360490497474"},{"issue":"2","key":"10.1016\/j.tmaid.2022.102289_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4161\/hv.4.2.5216","article-title":"Evaluation of two yellow fever vaccines for routine immunization programs in Argentina","volume":"4","author":"Ripoll","year":"2008","journal-title":"Hum Vaccine"},{"key":"10.1016\/j.tmaid.2022.102289_bib4","doi-asserted-by":"crossref","unstructured":"P. Cottin, M. Niedrig, and C. Domingo, \u201cSafety profile of the yellow fever vaccine Stamaril\u00ae: a 17-year review,\u201d Expert Rev Vaccines, vol. 12, no. 11, pp. 1351\u20131368, Nov. 2013.","DOI":"10.1586\/14760584.2013.836320"},{"issue":"5","key":"10.1016\/j.tmaid.2022.102289_bib6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.4269\/ajtmh.2002.66.533","article-title":"Comparative safety and immunogenicity of two yellow fever 17D vaccines (ARILVAX and YF-VAX) in a phase III multicenter, double-blind clinical trial","volume":"66","author":"Marchesani","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2022.102289_bib7","unstructured":"Yellow fever: the green book, [chapter 35] - GOV.UK.\u201d [Online]. Available:.https:\/\/www.gov.uk\/government\/publications\/yellow-fever-the-green-book-chapter-35. [Accessed: 04-Mar-2020]."},{"issue":"5","key":"10.1016\/j.tmaid.2022.102289_bib8","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taw045","article-title":"Adverse event reports following yellow fever vaccination, 2007-13","volume":"23","author":"Lindsey","year":"2016","journal-title":"J Trav Med"},{"issue":"27","key":"10.1016\/j.tmaid.2022.102289_bib9","first-page":"269","article-title":"Vaccines and vaccination against yellow fever. WHO position paper -- June 2013","volume":"88","year":"2013","journal-title":"Relev Epidemiol Hebd"},{"key":"10.1016\/j.tmaid.2022.102289_bib10","author":"Gershman"},{"key":"10.1016\/j.tmaid.2022.102289_bib11","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.2147\/DDDT.S99600","article-title":"Yellow fever vaccine-associated viscerotropic disease: current perspectives","volume":"10","author":"Thomas","year":"2016","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.tmaid.2022.102289_bib12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jcv.2014.08.030","article-title":"Yellow fever","volume":"64","author":"Monath","year":"2015","journal-title":"J Clin Virol"},{"key":"10.1016\/j.tmaid.2022.102289_bib14","doi-asserted-by":"crossref","unstructured":"A. A. Marfin, R. S. B. Eidex, P. E. Kozarsky, and M. S. Cetron, \u201cYellow fever and Japanese encephalitis vaccines: indications and complications,\u201d Infect Dis Clin, vol. 19, no. 1. pp. 151\u2013168, Mar-2005.","DOI":"10.1016\/j.idc.2004.11.004"},{"issue":"9438","key":"10.1016\/j.tmaid.2022.102289_bib15","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(04)17017-7","article-title":"Eidex and yellow fever vaccine safety working group, \u201chistory of thymoma and yellow fever vaccination","volume":"364","author":"Barwick","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.tmaid.2022.102289_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4269\/ajtmh.13-0542","article-title":"Defining risk groups to yellow fever vaccine-associated viscerotropic disease in the absence of denominator data","volume":"90","author":"Seligman","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.tmaid.2022.102289_bib18","series-title":"British HIV Association guidelines on the use of vaccines in HIV-positive adults 2015","author":"Brook","year":"2015"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893922000357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1477893922000357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:07:45Z","timestamp":1761487665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1477893922000357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":15,"alternative-id":["S1477893922000357"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2022.102289","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"National review of reported Yellow fever vaccine incidents in the UK","name":"articletitle","label":"Article Title"},{"value":"Travel Medicine and Infectious Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tmaid.2022.102289","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102289"}}